Ident. | Authors (with country if any) | Title |
---|
000020 (2021) |
Fabio Cruciani [Italie] ; Laura Amato [Italie] ; Franco De Crescenzo ; Zuzana Mitrova [Italie] ; Rosella Saulle [Italie] ; Simona Vecchi [Italie] ; Marina Davoli [Italie] | [The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.] |
000043 (2021) |
Albert Prats-Uribe [Royaume-Uni] ; Anthony G. Sena [États-Unis, Pays-Bas] ; Lana Yin Hui Lai [Royaume-Uni] ; Waheed-Ul-Rahman Ahmed [Royaume-Uni] ; Heba Alghoul ; Osaid Alser [États-Unis] ; Thamir M. Alshammari [Arabie saoudite] ; Carlos Areia [Royaume-Uni] ; William Carter [États-Unis] ; Paula Casajust [Espagne] ; Dalia Dawoud [Égypte, Royaume-Uni] ; Asieh Golozar [États-Unis] ; Jitendra Jonnagaddala [Australie] ; Paras P. Mehta [États-Unis] ; Mengchun Gong [République populaire de Chine] ; Daniel R. Morales [Royaume-Uni, Danemark] ; Fredrik Nyberg [Suède] ; Jose D. Posada [États-Unis] ; Martina Recalde [Espagne] ; Elena Roel [Espagne] ; Karishma Shah [Royaume-Uni] ; Nigam H. Shah [États-Unis] ; Lisa M. Schilling [États-Unis] ; Vignesh Subbian [États-Unis] ; David Vizcaya [Espagne] ; Lin Zhang [République populaire de Chine, Australie] ; Ying Zhang [République populaire de Chine] ; Hong Zhu [République populaire de Chine] ; Li Liu [République populaire de Chine] ; Jaehyeong Cho [Corée du Sud] ; Kristine E. Lynch [États-Unis] ; Michael E. Matheny [États-Unis] ; Seng Chan You [Corée du Sud] ; Peter R. Rijnbeek [Pays-Bas] ; George Hripcsak [États-Unis] ; Jennifer Ce Lane [Royaume-Uni] ; Edward Burn [Royaume-Uni, Espagne] ; Christian Reich [États-Unis] ; Marc A. Suchard [États-Unis] ; Talita Duarte-Salles [Espagne] ; Kristin Kostka [États-Unis] ; Patrick B. Ryan [Slovénie, États-Unis] ; Daniel Prieto-Alhambra [Royaume-Uni] | Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study. |
000044 (2021) |
Jason D. Goldman [États-Unis] ; George Diaz [États-Unis] ; Walter J. Urba [États-Unis] | Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature. |
000055 (2021) |
Tuan V. Nguyen [Australie] | Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load. |
000075 (2021) |
Sawsan Elgohary [Égypte] ; Aya A. Elkhodiry [Égypte] ; Nada S. Amin [Égypte] ; Ulrike Stein [Allemagne] ; Hend M. El Tayebi [Égypte] | Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients? |
000150 (2021) |
Philippe Gautret [France] ; Stéphane Honoré [France] ; Jean-Christophe Lagier [France] ; Didier Raoult [France] | Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients. |
000166 (2021) |
Giulia Fiscon [Italie] ; Federica Conte [Italie] ; Lorenzo Farina [Italie] ; Paola Paci [Italie] | SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19. |
000181 (2021) |
Pravindra Kumar [Inde] ; Ashok Kumar Sah [Inde] ; Greesham Tripathi [Inde] ; Anjali Kashyap [Inde] ; Avantika Tripathi [Inde] ; Rashmi Rao [Inde] ; Prabhu C. Mishra [Inde] ; Koustav Mallick [Inde] ; Amjad Husain [Inde] ; Manoj Kumar Kashyap [Inde] | Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19. |
000188 (2021) |
Veronique Michaud [États-Unis, Canada] ; Pamela Dow [États-Unis] ; Sweilem B. Al Rihani [États-Unis] ; Malavika Deodhar [États-Unis] ; Meghan Arwood [États-Unis] ; Brian Cicali [États-Unis] ; Jacques Turgeon [États-Unis, Canada] | Risk Assessment of Drug-Induced Long QT Syndrome for Some COVID-19 Repurposed Drugs. |
000190 (2021) |
Dingzhong Li [République populaire de Chine] ; Jianbing Hu [République populaire de Chine] ; Dian Li [République populaire de Chine] ; Weijun Yang [République populaire de Chine] ; Shuang-Feng Yin [République populaire de Chine] ; Renhua Qiu [République populaire de Chine] | Reviews on Biological Activity, Clinical Trial and Synthesis Progress of Small Molecules for the Treatment of COVID-19. |
000204 (2021) |
Evellyn Claudia Wietzikoski Lovato [Brésil] ; Lorena Neris Barboza [Brésil] ; Samantha Wietzikoski [Brésil] ; Amanda Nascimento Vasques De Souza [Brésil] ; Pablo Alvarez Auth [Brésil] ; Arquimedes Gasparotto Junior [Brésil] ; Francislaine Aparecida Dos Reis Lívero [Brésil] | Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19). |
000218 (2021) |
Marcelo Rodrigues Dos Santos [Brésil] | Referring to the study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial. |
000219 (2021) |
Fiona Marra [Royaume-Uni] ; Elise J. Smolders [Pays-Bas] ; Omar El-Sherif [Royaume-Uni] ; Alison Boyle [Royaume-Uni] ; Katherine Davidson [Royaume-Uni] ; Andrew J. Sommerville [Royaume-Uni] ; Catia Marzolini [Royaume-Uni, Suisse] ; Marco Siccardi [Royaume-Uni] ; David Burger [Pays-Bas] ; Sara Gibbons [Royaume-Uni] ; Saye Khoo [Royaume-Uni] ; David Back [Royaume-Uni] | Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment. |
000221 (2021) |
Seongman Bae [Corée du Sud] ; Byeongzu Ghang [Corée du Sud] ; Ye-Jee Kim [Corée du Sud] ; Joon Seo Lim [Corée du Sud] ; Sung-Cheol Yun [Corée du Sud] ; Yong-Gil Kim [Corée du Sud] ; Sang-Oh Lee [Corée du Sud] ; Sung-Han Kim [Corée du Sud] | Recent Hydroxychloroquine Use Is Not Significantly Associated with Positive PCR Results for SARS-CoV-2: A Nationwide Observational Study in South Korea. |
000265 (2021) |
Gayathri Baburaj [Inde] ; Levin Thomas [Inde] ; Mahadev Rao [Inde] | Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies. |
000294 (2021) |
Sanjay Kumar Mishra [Inde] ; Timir Tripathi [Inde] | One year update on the COVID-19 pandemic: Where are we now? |
000307 (2021) |
Shweta A. More [Inde] ; Akshay S. Patil [États-Unis] ; Nikhil S. Sakle [Inde] ; Santosh N. Mokale [Inde] | Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs. |
000317 (2021) |
Masashi Ohe [Japon] ; Ken Furuya [Japon] ; Houman Goudarzi [Japon] | Multidrug treatment for COVID-19. |
000326 (2021) |
C N Prashantha [Inde] ; K. Gouthami [Inde] ; L. Lavanya [Inde] ; Sivaramireddy Bhavanam [Inde] ; Ajay Jakhar [Inde] ; R G Shakthiraju [Inde] ; V. Suraj [Inde] ; K V Sahana [Inde] ; H S Sujana [Inde] ; N M Guruprasad [Inde] ; R. Ramachandra [Inde] | Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus. |
000338 (2021) |
Florence Rodgers [Royaume-Uni] ; Toby Pepperrell [Royaume-Uni] ; Sarai Keestra [Pays-Bas, Royaume-Uni] ; Victoria Pilkington [Royaume-Uni] | Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs. |
000352 (2021) |
Nicolas De Schryver [Belgique] ; Nicolas Serck [Belgique] ; Marco Vinetti [Belgique] ; Ludovic Gérard [Belgique] | Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality. |